BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Moon YW, Jeung HC, Rha SY, Yoo NC, Roh JK, Noh SH, Kim BS, Chung HC. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Ann Surg Oncol. 2007;14:2730-2737. [PMID: 17632757 DOI: 10.1245/s10434-007-9479-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Kim SH, Song BI, Kim HW, Won KS, Son YG, Ryu SW. Prognostic Value of Restaging F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict 3-Year Post-Recurrence Survival in Patients with Recurrent Gastric Cancer after Curative Resection. Korean J Radiol 2020;21:829-37. [PMID: 32524783 DOI: 10.3348/kjr.2019.0672] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Park S, Moon SK, Lim JW. Mechanism of metastasis to the spermatic cord and testis from advanced gastric cancer: a case report. BMC Gastroenterol 2020;20:119. [PMID: 32312237 DOI: 10.1186/s12876-020-01269-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kim JH, Kim DS, Cho HD, Lee MS. Late-onset metastatic adenocarcinoma of the spermatic cord from primary gastric cancer. World J Surg Oncol 2014;12:128. [PMID: 24767516 DOI: 10.1186/1477-7819-12-128] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
4 Lu X, Yang P, Zhao X, Jiang M, Hu S, Ouyang Y, Zeng L, Wu J. OGDH mediates the inhibition of SIRT5 on cell proliferation and migration of gastric cancer. Exp Cell Res 2019;382:111483. [PMID: 31247190 DOI: 10.1016/j.yexcr.2019.06.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 5.5] [Reference Citation Analysis]
5 Harada M, Tsujimoto H, Ichikura T, Nagata H, Ito N, Nomura S, Horiguchi H, Yaguchi Y, Kishi Y, Ueno H. A case of a long-term survival achieved by surgical treatment and chemotherapy for late recurrence of AFP-producing gastric cancer. Surg Case Rep 2019;5:106. [PMID: 31264022 DOI: 10.1186/s40792-019-0664-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Figueroa-Giralt M, Csendes A, Carrillo K, Danilla S, Lanzarini E, Braghetto I, Musleh M, Cortés S. INTRODUCTION OF THE NEW LYMPHOPARIETAL INDEX FOR GASTRIC CANCER PATIENTS. Arq Bras Cir Dig 2019;32:e1441. [PMID: 31460601 DOI: 10.1590/0102-672020190001e1441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 András C, Tóth L, Pósán J, Csiki E, Tanyi M, Csiki Z, Garami Z, Enyedi A, Flaskó T, Horváth Z. Occurrence of bladder metastasis 10 years after surgical removal of a primary gastric cancer: a case report and review of the literature. J Med Case Rep. 2013;7:204. [PMID: 23945465 DOI: 10.1186/1752-1947-7-204] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Matsunaga T, Satio H, Miyauchi W, Shishido Y, Miyatani K, Murakami Y, Hanaki T, Kihara K, Yamamoto M, Tokuyasu N, Takano S, Sakamoto T, Hasegawa T, Fujiwara Y. Impact of skeletal muscle mass in patients with recurrent gastric cancer. World J Surg Oncol 2021;19:170. [PMID: 34116681 DOI: 10.1186/s12957-021-02283-6] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Okugawa Y, Toiyama Y, Inoue Y, Saigusa S, Kobayashi M, Tanaka K, Mohri Y, Miki C, Kusunoki M. Late-onset peritoneal recurrence of advanced gastric cancer 20 years after primary resection. World J Surg Oncol 2010;8:104. [PMID: 21092332 DOI: 10.1186/1477-7819-8-104] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
10 Tatsubayashi T, Tanizawa Y, Miki Y, Tokunaga M, Bando E, Kawamura T, Sugiura T, Kinugasa Y, Uesaka K, Terashima M. Treatment outcomes of hepatectomy for liver metastases of gastric cancer diagnosed using contrast-enhanced magnetic resonance imaging. Gastric Cancer. 2017;20:387-393. [PMID: 27155874 DOI: 10.1007/s10120-016-0611-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 5.6] [Reference Citation Analysis]
11 Jiang Z, Wang X, Li J, Yang H, Lin X. Aldolase A as a prognostic factor and mediator of progression via inducing epithelial-mesenchymal transition in gastric cancer. J Cell Mol Med 2018;22:4377-86. [PMID: 29992789 DOI: 10.1111/jcmm.13732] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
12 Mei LJ, Yang XJ, Tang L, Hassan AH, Yonemura Y, Li Y. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer. BMC Cancer 2010;10:124. [PMID: 20359350 DOI: 10.1186/1471-2407-10-124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
13 Ma X, Huang M, Wang Z, Liu B, Zhu Z, Li C. ZHX1 Inhibits Gastric Cancer Cell Growth through Inducing Cell-Cycle Arrest and Apoptosis. J Cancer 2016;7:60-8. [PMID: 26722361 DOI: 10.7150/jca.12973] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
14 Tang Z, Li L, Tang Y, Xie D, Wu K, Wei W, Xiao Q. CDK2 positively regulates aerobic glycolysis by suppressing SIRT5 in gastric cancer. Cancer Sci 2018;109:2590-8. [PMID: 29896817 DOI: 10.1111/cas.13691] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
15 Park JS, Choe EA, Park S, Nam CM, Hyung WJ, Noh SH, Lee S, Kim HS, Jung M, Chung HC, Rha SY. Detection of asymptomatic recurrence improves survival of gastric cancer patients. Cancer Med 2021;10:3249-60. [PMID: 33932104 DOI: 10.1002/cam4.3899] [Reference Citation Analysis]
16 Li C, Nie H, Wang M, Su L, Li J, Yu B, Wei M, Ju J, Yu Y, Yan M. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett. 2012;320:189-197. [PMID: 22388101 DOI: 10.1016/j.canlet.2012.02.030] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.0] [Reference Citation Analysis]
17 Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. 2017;8:20741-20750. [PMID: 28186964 DOI: 10.18632/oncotarget.15119] [Cited by in Crossref: 118] [Cited by in F6Publishing: 121] [Article Influence: 29.5] [Reference Citation Analysis]
18 Lee JH, Kim HI, Kim MG, Ha TK, Jung MS, Kwon SJ. Recurrence of gastric cancer in patients who are disease-free for more than 5 years after primary resection. Surgery 2016;159:1090-8. [PMID: 26747230 DOI: 10.1016/j.surg.2015.11.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
19 Qi W, Yang Z, Li H, Cui Y, Xuan Y. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis. APMIS 2019;127:64-71. [PMID: 30698309 DOI: 10.1111/apm.12919] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Deng J, Zhang Q, Lu L, Fan C. Long Noncoding RNA DLGAP1-AS1 Promotes the Aggressive Behavior of Gastric Cancer by Acting as a ceRNA for microRNA-628-5p and Raising Astrocyte Elevated Gene 1 Expression. Cancer Manag Res 2020;12:2947-60. [PMID: 32431541 DOI: 10.2147/CMAR.S246166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
21 Zhang JK, Li YS, Zhang CD, Dai DQ. Up-regulation of CRKL by microRNA-335 methylation is associated with poor prognosis in gastric cancer. Cancer Cell Int 2017;17:28. [PMID: 28239297 DOI: 10.1186/s12935-017-0387-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
22 Valletti M, Eshmuminov D, Gnecco N, Gutschow CA, Schneider PM, Lehmann K. Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytology. World J Surg Oncol 2021;19:245. [PMID: 34404403 DOI: 10.1186/s12957-021-02351-x] [Reference Citation Analysis]
23 Zhao H, Xiao H, Lu Y, Liu S, Wang C. Long noncoding RNA LINC00339 promotes the oncogenicity of gastric cancer by regulating SRY-box 9 expression via sponging of microRNA-539. Cell Cycle 2020;19:1143-57. [PMID: 32308105 DOI: 10.1080/15384101.2020.1749404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
24 Xu D, Qu L, Hu J, Li G, Lv P, Ma D, Guo M, Chen Y. Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis. J Cell Mol Med 2014;18:1655-66. [PMID: 24975047 DOI: 10.1111/jcmm.12352] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
25 许牧, 曹毅, 蒋蒙蒙, 揭志刚, 李正荣. miR495、miR551a靶向干扰PRL-3表达抑制胃癌腹膜转移. 世界华人消化杂志 2013; 21(18): 1693-1700 [DOI: 10.11569/wcjd.v21.i18.1693] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Ota Y, Matsuyama R, Taniguchi K, Ueda M, Takeda K, Tanaka K, Nakayama T, Endo I. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clin J Gastroenterol 2013;6:485-9. [PMID: 24319501 DOI: 10.1007/s12328-013-0432-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
27 Baiocchi GL, Marrelli D, Verlato G, Morgagni P, Giacopuzzi S, Coniglio A, Marchet A, Rosa F, Capponi MG, Di Leo A. Follow-up after gastrectomy for cancer: an appraisal of the Italian research group for gastric cancer. Ann Surg Oncol. 2014;21:2005-2011. [PMID: 24526547 DOI: 10.1245/s10434-014-3534-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 27] [Article Influence: 1.4] [Reference Citation Analysis]
28 Yang XJ, Li Y, Yonemura Y. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center. J Surg Oncol 2010;101:457-64. [PMID: 20401915 DOI: 10.1002/jso.21519] [Cited by in Crossref: 62] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
29 Chen H, Li L, Wang S, Lei Y, Ge Q, Lv N, Zhou X, Chen C. Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-A. Oncotarget 2014;5:11873-85. [PMID: 25428912 DOI: 10.18632/oncotarget.2662] [Cited by in Crossref: 85] [Cited by in F6Publishing: 87] [Article Influence: 14.2] [Reference Citation Analysis]
30 Wang YN, Shen KT, Ling JQ, Gao XD, Hou YY, Wang XF, Qin J, Sun YH, Qin XY. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases. BMC Surg. 2012;12:20. [PMID: 23062030 DOI: 10.1186/1471-2482-12-20] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
31 Uemura N, Kurashige J, Kosumi K, Iwatsuki M, Yamashita K, Iwagami S, Baba Y, Sakamoto Y, Miyamoto Y, Yoshida N, Honda Y, Mikami Y, Baba H. Early gastric cancer metastasizing to the rectum, possibly via a hematogenous route: a case report and review of literature. Surg Case Rep 2016;2:58. [PMID: 27271470 DOI: 10.1186/s40792-016-0180-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
32 Wu X, Chen X, Zhou Q, Li P, Yu B, Li J, Qu Y, Yan J, Yu Y, Yan M, Zhu Z, Liu B, Su L. Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Lett 2013;335:128-35. [PMID: 23402812 DOI: 10.1016/j.canlet.2013.02.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 6.3] [Reference Citation Analysis]
33 Blanchette P, Lipton JH, Barth D, Mackay H. Case report of very late gastric cancer recurrence. Curr Oncol 2013;20:e161-4. [PMID: 23559883 DOI: 10.3747/co.20.1200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
34 Iovino F, Orditura M, Auriemma PP, Ciorra FR, Giordano G, Orabona C, Bara F, Sergio R, Savastano B, Fabozzi A, Laterza MM, Ventriglia J, Petrillo A, Della Corte CM, DE Vita F. Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. Oncol Lett 2015;9:1403-5. [PMID: 25663920 DOI: 10.3892/ol.2014.2822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
35 Wang X, Che X, Liu C, Fan Y, Bai M, Hou K, Shi X, Zhang X, Liu B, Zheng C, Liu Y, Qu X. Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Experimental Cell Research 2018;368:184-93. [DOI: 10.1016/j.yexcr.2018.04.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
36 Shin CH, Lee WY, Hong SW, Chang YG. Characteristics of gastric cancer recurrence five or more years after curative gastrectomy. Chin J Cancer Res. 2016;28:503-510. [PMID: 27877009 DOI: 10.21147/j.issn.1000-9604.2016.05.05] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
37 Liakakos T. Peritoneal recurrence for gastric cancer: can it be prevented? Ann Surg Oncol 2008;15:382. [PMID: 17896142 DOI: 10.1245/s10434-007-9586-2] [Reference Citation Analysis]
38 Watanabe M, Suzuki H, Maejima K, Komine O, Mizutani S, Yoshino M, Bo H, Kitayama Y, Uchida E. Surgical resection of late solitary locoregional gastric cancer recurrence in stomach bed. Med Sci Monit 2012;18:CS53-6. [PMID: 22739738 DOI: 10.12659/msm.883196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Yago A, Haruta S, Ueno M, Hamada Y, Ogawa Y, Ohkura Y, Urabe M, Udagawa H. Adequate period of surveillance in each stage for curatively resected gastric cancer: analyzing the time and rates of recurrence. Gastric Cancer 2021;24:752-61. [PMID: 33400037 DOI: 10.1007/s10120-020-01147-4] [Reference Citation Analysis]
40 Cho S, Choi JY, Kim JY, Seo KW, Chang HK, Park Y, Kim BS. Solitary osteolytic skull metastasis as the only recurrence of advanced gastric cancer: a case report and literature review. British Journal of Neurosurgery. [DOI: 10.1080/02688697.2018.1498968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
41 Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010;298:50-63. [PMID: 20619534 DOI: 10.1016/j.canlet.2010.06.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 192] [Article Influence: 17.6] [Reference Citation Analysis]
42 Ogasawara N, Ohkura Y, Ueno M, Haruta S, Nakayama A, Fujii T, Honda A, Tanaka T, Udagawa H. Late recurrence of gastric carcinoma 15 years after surgery. Clin J Gastroenterol 2020;13:746-53. [PMID: 32508000 DOI: 10.1007/s12328-020-01143-2] [Reference Citation Analysis]
43 Zhu M, Zhang N, He S, Yan R, Zhang J. MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo. Clin Exp Metastasis 2016;33:509-19. [PMID: 27142596 DOI: 10.1007/s10585-016-9795-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
44 Yasuda T, Hayashi S, Nakahata Y, Yasuda Y, Omatsu T, Obora A, Kojima T, Yagi N. Recurrence of Cutaneous and Lymph Node Metastases 12 Years after Radical Total Gastrectomy for Stage IIA Gastric Cancer. Intern Med 2020;59:1387-93. [PMID: 32132333 DOI: 10.2169/internalmedicine.3847-19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]